ArticleJournal of cancer research and clinical oncology2022

Quality of life in lung cancer survivors treated with tyrosine-kinase inhibitors (TKI): results from the multi-centre cross-sectional German study LARIS.

Nicola Riccetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.